STOCK TITAN

Justera Health Announces Management Change

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

Justera Health (CSE:VTAL)(OTC PINK:SCRSF) announces leadership changes as Young Cho Lee steps down as CEO effective November 15, 2024. The company's Director, Joshua Herman, has been appointed as the new Chief Executive Officer. Herman, bringing extensive public company experience, will focus on driving the company's growth and delivering value to stakeholders.

Justera Health (CSE:VTAL)(OTC PINK:SCRSF) annuncia cambiamenti nel vertice aziendale, poiché Young Cho Lee si dimetterà da CEO con effetto dal 15 novembre 2024. Il Direttore dell'azienda, Joshua Herman, è stato nominato nuovo Amministratore Delegato. Herman, con una vasta esperienza in aziende pubbliche, si concentrerà sulla crescita dell'azienda e sulla creazione di valore per gli azionisti.

Justera Health (CSE:VTAL)(OTC PINK:SCRSF) anuncia cambios en el liderazgo, ya que Young Cho Lee deja su puesto como CEO a partir del 15 de noviembre de 2024. El Director de la empresa, Joshua Herman, ha sido nombrado nuevo Director Ejecutivo. Herman, quien aporta una amplia experiencia en empresas públicas, se enfocará en impulsar el crecimiento de la compañía y en entregar valor a los interesados.

Justera Health (CSE:VTAL)(OTC PINK:SCRSF)가 Young Cho Lee가 2024년 11월 15일부로 CEO직에서 물러난다고 발표하면서 리더십 변화를 알렸습니다. 회사의 이사인 Joshua Herman이 새로운 CEO로 임명되었습니다. 허먼은 넓은 공기업 경험을 바탕으로 회사의 성장 촉진 및 이해관계자에 대한 가치 제공에 주력할 것입니다.

Justera Health (CSE:VTAL)(OTC PINK:SCRSF) annonce un changement de direction, alors que Young Cho Lee démissionne de son poste de PDG à compter du 15 novembre 2024. Le Directeur de l'entreprise, Joshua Herman, a été nommé nouveau Directeur Général. Herman, qui apporte une vaste expérience des sociétés cotées en bourse, se concentrera sur la croissance de l'entreprise et la création de valeur pour les parties prenantes.

Justera Health (CSE:VTAL)(OTC PINK:SCRSF) kündigt Führungswechsel an, da Young Cho Lee mit Wirkung zum 15. November 2024 als CEO zurücktritt. Der Direktor des Unternehmens, Joshua Herman, wurde zum neuen Geschäftsführer ernannt. Herman, der über umfassende Erfahrungen in börsennotierten Unternehmen verfügt, wird sich auf das Wachstum des Unternehmens und die Schaffung von Werten für die Stakeholder konzentrieren.

Positive
  • None.
Negative
  • None.

TORONTO, ON / ACCESSWIRE / November 15, 2024 / Justera Health Ltd. (CSE:VTAL)(OTC PINK:SCRSF) ("Justera"or the"Company") is pleased to announce the changes to the leadership to the Company.

The Company regrets to announce that effective November 15, 2024, Mr. Young Cho Lee has stepped down as Chief Executive Officer of the Company.

In response to Mr. Lee's departure, the Company's Director, Mr. Joshua Herman has taken the vacancy of Chief Executive Officer position. Mr. Herman brings extensive public company experience and has a key role in steering the Company's strategic vision. The Board is confident that MR. Herman will provide the strong leadership needed.

"I am deeply honoured and grateful to be appointed as the CEO of this esteemed organization. I am looking forward to working along side our talented team to continue driving the Company's growth and success. We will navigate the challenges ahead together with a focus on delivering value to our stakeholders and positive impact," said Joshua Herman, the new CEO of the Company.

The Company wishes the former CEO, Mr. Lee, the best for his future endeavors.

About Justera Health

Established in 2020, Justera is a Canadian company focused on health and wellness. Through its services, innovative products, strategic partnerships, Justera empowers individuals to prioritize their well-being. With four subsidiaries, it offers personalized healthcare services and solutions, such as IV Vitamin Therapy, premium nutritional supplements through its Naturevan Nutrition brand, a full 360-degree wellness and spa experience through Juillet Wellness that provides registered massage therapy, acupuncture, and new retail stores in Vancouver. Justera's mission is to enhance Canadians overall well-being with diverse solutions catering to individual needs.

For additional information on Justera Health and other corporate information, please visit the Company's website at https://www.justerahealth.com/

For more information about the Company, please refer to the Company's profile on SEDAR+ at www.sedarplus.com.

For further information:

Investor Relations & Communications
Paul Haber, CFO
Tel: (416) 318-6501
Email: info@justerahealth.com

Forward-Looking Statements:

Certain statements contained in this news release may constitute forward-looking information, including statements relating to the future development of Justera's business. Forward-looking information is often, but not always, identified by the use of words such as "anticipate", "plan", "estimate", "expect", "may", "will", "intend", "should", and similar expressions.All statements included herein, other than statements of historical fact, are forward-looking ‎statements, including but not limited to: the terms, timing and completion of the Transaction, if the Transaction is to close at all, the receipt of all necessary regulatory and CSE approvals, authorizations and consents in connection with the Transaction, and the completion or waiver, as applicable, of all conditions precedent required for the completion of the Transaction; the anticipated business plans, management structure, and future activities of the Company and Port North, including the Company's intention to integrate Port North into its business; and the anticipated benefits and synergies to be derived from the Transaction on the business of both Port North and the Company; and the date in which the Payment Shares may become free-trading.

Forward-Looking Statements are based on assumptions, estimates, analyses and opinions of management of the Company at the time they were provided or made in light of its experience and its perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances, including: (i) successful completion of the Financing; (ii) successful completion of the Transaction and the integration of the business of Port North in connection therewith; (iii) the ability to manage anticipated and unanticipated costs; (iv) achieving the anticipated results of the Company's strategic plans; (v) obtaining and maintaining all required licenses, approvals and permits, including regulatory approvals required to complete the Transaction; and (vi) general economic, financial market, regulatory and political conditions in which the Company operates.

Forward-looking information involves known and unknown risks, uncertainties, and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking information. The actual results of Justera could differ materially from those anticipated in this forward-looking information as a result of the inability of Port North to complete the Financing, the inability to consummate the Transaction, including the inability to obtain required regulatory approvals and third-party consents and the satisfaction of other conditions, inputs, suppliers and skilled labour being unavailable or available only at uneconomic costs; changes in general economic, business and political conditions, including changes in the financial markets, changes in applicable laws generally and adverse future legislative and regulatory developments involving medical and recreational marijuana, competitive factors in the industries in which Justera operates, prevailing economic conditions, changes to Justera's strategic growth plans, and other factors, many of which are beyond the control of Justera.

Management of Justera believes that the expectations reflected in the forward-looking information herein are reasonable, but no assurance can be given that these expectations will prove to be correct and such forward-looking information should not be unduly relied upon. Any forward‐looking information contained in this news release represents Justera's expectations as of the date hereof and is subject to change after such date. Justera disclaims any intention or obligation to update or revise any forward‐looking information whether as a result of new information, future events, or otherwise, except as required by applicable securities legislation.

Neither the Canadian Securities Exchange (the "CSE") nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

###

SOURCE: Justera Health Ltd.



View the original press release on accesswire.com

FAQ

Who is the new CEO of Justera Health (SCRSF) as of November 15, 2024?

Joshua Herman, previously a Director of Justera Health, has been appointed as the new CEO of the company.

Why did Young Cho Lee leave Justera Health (SCRSF)?

The press release does not specify the reason for Young Cho Lee's departure as CEO from Justera Health.

When did the CEO change at Justera Health (SCRSF) take effect?

The CEO change at Justera Health took effect on November 15, 2024.

JUSTERA HEALTH LTD

OTC:SCRSF

SCRSF Rankings

SCRSF Latest News

SCRSF Stock Data

883.97k
242.98M
1.99%
Diagnostics & Research
Healthcare
Link
United States of America
Toronto